Trial Profile
Comparison of the analgesic efficacy of neosaxitoxin and bupivacaine for the prevention of postoperative pain in patients undergoing laparoscopic surgery for gallbladder removal.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 May 2011
Price :
$35
*
At a glance
- Drugs Neosaxitoxin (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 01 Apr 2011 Primary endpoint 'incisional pain 12 hours postoperatively, assessed by visual analogue scale pain scores' has been met.
- 01 Apr 2011 Results published in Regional Anesthesia and Pain Medicine.
- 25 Feb 2011 New trial record